How to define the relative contraindications to oral anticoagulant therapy

Submitted: May 16, 2017
Accepted: May 16, 2017
Published: August 28, 2017
Abstract Views: 1202
PDF: 730
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


There is currently a lack of consensus on which anticoagulant therapy contraindications should be considered “absolute†and which should be considered “relativeâ€. Guidelines do not clearly identify absolute and relative contraindications to anticoagulant therapy. Recent guidelines on AF of the European Society of Cardiology underline the relevance of several factors and their use in scores, leaving anyway space to the clinical judgment of the physician. A high bleeding risk score should generally not result per se in a contraindication to anticoagulant therapy. Rather, bleeding risk factors should be identified and treatable factors corrected. A combined use of a more hierarchical classification of the different bleeding risk factors and the risk scores probably represents the best approach to maximize the benefit of anticoagulant therapy in various clinical settings.



PlumX Metrics


Download data is not yet available.


How to Cite

Pedretti, Roberto F.E. 2017. “How to Define the Relative Contraindications to Oral Anticoagulant Therapy”. Monaldi Archives for Chest Disease 87 (2).